EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Reversing Antibiotic Resistance: Strategies From Adjuvants to Innovative Therapeutics

Tianjiao Li, Fei Zeng, Jie Zhang, Yuangong Zhang, Wenjuan Yin

MicrobiologyOpen · 2026-02 · 15 (1)

DOI: 10.1002/mbo3.70233 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift MicrobiologyOpen, online erschienen am 15.02.2026. Verfasst von Tianjiao Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Basic Medical Science, Key Laboratory of Pathogenesis Mechanism and Control of Inflammatory-Autoimmune Diseases of Hebei Province, Hebei U…. Hauptthemen laut MEDLINE: Drug Resistance, Bacterial, Bacterial Infections, Anti-Bacterial Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 145 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Hebei Province, The Medical Scientific Research of Hebei Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The escalating prevalence of antibiotic resistance has become a major threat to the effectiveness of conventional antibiotics. Meanwhile, the development of novel antibiotics faces substantial challenges, including lengthy research cycles, high costs, and the rapid emergence of bacterial tolerance, making it difficult for new drugs to keep pace with bacterial evolution. In this context, molecular reversal strategies targeting antibiotic resistance genes have emerged as a promising avenue to overcome this impasse. Among them, the use of antibiotic adjuvants, agents that enhance the efficacy of existing antibiotics by inhibiting resistance gene function, preventing their horizontal transfer or modulating host defense has gained considerable attention. Furthermore, innovative approaches such as CRISPR‐Cas gene editing, photodynamic therapy, nanotechnology, and ecological competition strategies have shown great potential in reversing antimicrobial resistance. Collectively, these strategies offer novel insights into addressing the global crisis of antibiotic resistance, paving the way for more effective clinical interventions and ensuring the sustained efficacy of current antibiotic therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistance, BacterialBacterial InfectionsAnti-Bacterial AgentsBacteriaHumansAnimalsGene Transfer, HorizontalHost-Directed TherapyGene EditingCRISPR-Cas SystemsPhotochemotherapyDrug Therapy, Combinationbeta-Lactamase Inhibitors

Stichwörter der Autor:innen

antibiotic adjuvantsantimicrobial resistanceinnovative strategiesmolecular mechanismsreverse resistance

Substanzen

Anti-Bacterial Agentsbeta-Lactamase Inhibitors

Autor:innen und Institutionen

  • College of Basic Medical Science, Key Laboratory of Pathogenesis Mechanism and Control of Inflammatory-Autoimmune Diseases of Hebei Province, Hebei University, Baoding, China.

Förderung

  • Natural Science Foundation of Hebei Province
  • The Medical Scientific Research of Hebei Health Commission

Zitieren

APA

Li, T., Zeng, F., Zhang, J., Zhang, Y., & Yin, W. (2026). Reversing Antibiotic Resistance: Strategies From Adjuvants to Innovative Therapeutics. MicrobiologyOpen, 15(1). https://doi.org/10.1002/mbo3.70233

Vancouver

Li T, Zeng F, Zhang J, Zhang Y, Yin W. Reversing Antibiotic Resistance: Strategies From Adjuvants to Innovative Therapeutics. MicrobiologyOpen. 2026;15(1). doi:10.1002/mbo3.70233

BibTeX
@article{Li2026,
  author = {Li, Tianjiao and Zeng, Fei and Zhang, Jie and Zhang, Yuangong and Yin, Wenjuan},
  title = {Reversing Antibiotic Resistance: Strategies From Adjuvants to Innovative Therapeutics},
  journal = {MicrobiologyOpen},
  year = {2026},
  volume = {15},
  number = {1},
  doi = {10.1002/mbo3.70233}
}
Kostenlos starten →